The US Food and Drug Administration (FDA) has granted orphan drug exclusivity to Hyperion's Ravicti (glycerol phenylbutyrate) liquid. Hyperion Therapeutics president and CEO Donald Santel said that the orphan drug exclusivity further ...
Tags: Hyperion, Ravicti Liquid